Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. The company is headquartered in Tarrytown, New York and currently employs 15,106 full-time employees.  The firm invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The firm is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.

Regeneron Pharmaceuticals, Inc. adalah perusahaan bioteknologi yang terlibat dalam penemuan, penciptaan, pengembangan, pembuatan, dan komersialisasi obat-obatan. Perusahaan ini berkantor pusat di Tarrytown, New York dan saat ini mempekerjakan 15.106 karyawan penuh waktu. Perusahaan ini menciptakan, mengembangkan, memproduksi, dan mengkomersialkan obat-obatan untuk orang-orang dengan penyakit serius. Produk dan kandidat produk yang sedang dalam pengembangan dirancang untuk membantu pasien dengan penyakit mata, penyakit alergi dan inflamasi, kanker, penyakit kardiovaskular dan metabolik, penyakit neurologis, kondisi hematologis, penyakit menular, dan penyakit langka. Perusahaan ini mempercepat pengembangan obat menggunakan teknologi kepemilikan, seperti VelociSuite, yang menghasilkan antibodi manusia yang sepenuhnya teroptimasi dan kelas baru antibodi bispesifik. VelociSuite terdiri dari VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, dan teknologi terkait lainnya. Produk yang dipasarkan termasuk EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, dan lainnya.

Regeneron

Google

Apple

JPMorgan

Oracle

MasterCard

Johnson & Johnson

SPDR S&P500 ETF

Costco

Bank of America

General Electric

Vanguard Total Stock Market ETF

Caterpillar

Cisco

AstraZeneca

Lam Research

Merck

Novartis

Raytheon Technologies

Philip Morris

Salesforce

Intel

Intuitive Surgical

Disney

Invesco QQQ Trust

PepsiCo

S&P Global

Pfizer

TotalEnergies

Deere

Progressive

CrowdStrike

Sanofi

Comcast

Vanguard Dev Markets ETF

Carvana

Agnico Eagle

Vanguard Value ETF

General Dynamics

Vanguard Total Bond Market ETF

Doordash Inc

Airbnb

Freeport-McMoRan

ING Groep

Royal Caribbean

Monster Beverage

Vanguard DivApp ETF

Corning

Johnson Controls

Williams Companies

Marvell Technology

Vanguard Emerging Markets ETF

Seagate Technology

Quanta Services

Motorola Solutions

iShares Russell 2000 ETF

Manulife Financial

iShares 20+ Year Treasury ETF

Air Products

Vanguard Total Intl Bond ETF

AFLAC

Suncor Energy

Vanguard High Dividend ETF

Digital Realty

Vanguard Info Tech ETF

Baidu

Chipotle

Anglogold Ashanti

Baker Hughes

DR Horton

Rockwell Automation

MSCI

eBay

Financial Select Sector SPDR

Estee Lauder

Prudential Financial (US)

Las Vegas Sands

Block, Inc.

Health Care Select Sector SPDR

Garmin

Coupang

Kinross Gold

Atlassian

Nucor

Energy Select Sector SPDR

Old Dominion

Expedia

Con Edison

Vanguard Real Estate ETF

Live Nation

SPDR Dow Jones ETF

Xylem

SoFi Technologies

iShares MBS ETF

iShares iBoxx Corp Bond ETF

iShares 7-10 Year Treasury ETF

Regeneron Stock

About Regeneron

Key Statistics